Scientific article

Quelle insuline pour quel patient en 2014 ?

ContributorsPhilippe, Jacques
Published inRevue médicale suisse, vol. 10, no. 433, p. 1230-1234
Publication date2014

Initiation of insulin treatment is a major step in the care of type 2 diabetic patients; it implicates a thorough discussion with the patient, therapeutic education and objectives shared by both physician and patient. The standard is an injection of basal insulin per day with either NPH insulin or a basal insulin analogue, such as detemir, glargine or degludec. The basal analogues have less side effects, weight gain and hypoglycemia, a more reproductible profile and a longer duration of action compared to NPH insulin. The injection can be made in the evening or in the morning depending on the dose and the glycemic profile. Oral antidiabetics can be maintained. More complicated insulin regimen are sometimes necessary but often induce more side effects with less compliance and little additional benefits.

  • Choice Behavior
  • Diabetes Mellitus, Type 2/drug therapy
  • Humans
  • Hypoglycemic Agents/therapeutic use
  • Insulin/therapeutic use
  • Practice Guidelines as Topic
Citation (ISO format)
PHILIPPE, Jacques. Quelle insuline pour quel patient en 2014 ? In: Revue médicale suisse, 2014, vol. 10, n° 433, p. 1230–1234.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation11/23/2015 2:34:00 PM
First validation11/23/2015 2:34:00 PM
Update time03/14/2023 11:58:21 PM
Status update03/14/2023 11:58:21 PM
Last indexation01/16/2024 7:49:35 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack